Answers are grounded in this paper and cite their sources.
Strains of pneumococci resistant to antimicrobial agents have now been reported from all continents and have become the predominant pathogens in some areas, with many strains being multiply resistant. Because of the importance of pneumococci in the aetiology of meningitis, strains with minimal inhibitory concentrations (MICs) of penicillin G of ≤0.06 mgl−1 are regarded as susceptible, while MICs of 0.1 to 1 mgl−1 are intermediate and MICs of >1 mgl−1 are resistant. Detection, susceptibility testing methods, and therapy of resistant pneumococcal infections are covered in this review. Susceptibility testing methods have now been well defined for use with pneumococci and screening for penicillin resistance with 1 μg oxacillin discs should be performed on all clinically-significant isolates. The activity of other β-lactams against penicillin-resistant strains has been documented, and MICs of other classes of agents have been described. Treatment of resistant pneumococcal infections is based on the site of infection, degree of penicillin resistance and resistance of the infecting strain to other agents, severity of disease, presence of underlying conditions, and dose and route of administration of antimicrobial agents. Current treatment recommendations are empiric or based on retrospective case studies, and adequate prospective studies need to be performed to provide more definitive data.
No takes yet. Share an insight, caveat, or question.
Jacobs et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: